Table 2.
Summary of cytogenetic data in 15 patients with giant cell tumor of bone
| Involvement in ≥ 2 TAsa | Clonal abnormalities | ||||
|---|---|---|---|---|---|
| Case | Chromosome telomere | No. of cellsb | Abnormality | No. of cells | Nonclonal abnormalities |
| 1 | 2qter | 2 | t(5;10)(p13;q22) | 3 | t(14;18)(q24;q21) |
| 9qter | 2 | del(5)(q13q33) | |||
| 12pter | 3 | der(11)(t(11;?)(q13;?) | |||
| 19qter | 6 | der(19)t(19;?)(q13;?) | |||
| 20qter | 5 | ||||
| 2 | 15pter | 3 | Ø | t(l5;21)(p11;q11) | |
| t(14;21)(p12;p13) | |||||
| t(8;22)(ql3;ql3) | |||||
| 3 | 5pter | 5 | der(20)t(13;20)(q12;q13) | 3 | del(15)(q13q26) |
| 8qter | 2 | del(9)(p13p22) | 2 | der(16)t(13;16)(q12;q22) | |
| 10pter | 2 | −X, −8, −15, −20 | 4 | ||
| 11pter | 3 | −9 | 5 | ||
| 16pter | 2 | +16 | 2 | ||
| 20qter | 3 | −19 | 3 | ||
| 4 | 19qter | 3 | Ø | t(6;19)(q15:q13) | |
| t(14;19)(q22;q13) | |||||
| t(3;4)(q25;q21) | |||||
| del(3)(p21p23) | |||||
| del(18)(q12.2) | |||||
| 5 | 3pter | 2 | −22 | 4 | der(5)t(5;?)(p15;?) |
| 9pter | 2 | del(11)(q22q23) | |||
| 11pter | 4 | der(3)t(3;?)(p11;?) | |||
| 16pter | 2 | ||||
| 19qter | 2 | ||||
| 6 | 7qter | 2 | Ø | der(12)t(8;12)(q11;p11) | |
| 7 | Ø | Ø | del(2)(p13) | ||
| del(19)(q11) | |||||
| der(11)t(11;?)(p13;?) | |||||
| 8 | 8pter | 3 | dic(11;19)(p15;q13) | 2 | |
| 11pter | 3 | ||||
| 19qter | 6 | ||||
| 22pter | 3 | ||||
| 22qter | 2 | ||||
| 9 | 19qter | 14 | der(19)t(19;?)(q13;?)c | 14 | der(2)t(2;?)(?q37;?) |
| −X,t(1;3)(p32;q21) | 15 | ||||
| 10 | Ø | Ø | del(8)(p11.2) | ||
| 11 | 5qter | 2 | Ø | double ring = 1 | |
| 14qter | 5 | double minute = 1 | |||
| 21qter | 3 | marker 15 = 1 | |||
| 12 | Ø | Ø | |||
| 13 | 10pter | 2 | ring 17 | 2 | |
| 14 | Ø | Ø | |||
| 15 | 16pter | 2 | 2 markers | ||
| −22 = 2 | |||||
TA, telomeric association, see text.
Some cells may contain 2 TA’s involving the same terminus.
3 different slides.